Read More

Atara Biotherapeutics Submits Tabelecleucel BLA For Treatment Of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease With U.S. FDA; Acceptance Of BLA Will Trigger $20M Milestone Payment From Pierre Fabre Laboratories, With Potential…

First Allogeneic T-Cell Therapy BLA Submission to U.S. Food and Drug AdministrationIf Approved, Tab-cel Would be First Approved Therapy in U.S. for EBV+ PTLDAcceptance of BLA Will Trigger $20 Million Milestone Payment

ATRA

Read More

Why Is Marketing Solutions Provider Global-E Online’s Stock Surging Today?

Global-E Online shares surged after the company reported Q1 FY24 revenue of $145.90 million, beating estimates. Sales grew 24% Y/Y, while GMV increased 32% to $930 million. Non-GAAP gross profit rose 36% to $66.1 million. The company raised its FY24 sales forecast to $733 million - $773 million. CEO Amir Schlachet highlighted significant client additions and business expansion.

GLBE